Randomised controlled trial of GM-CSF in critically ill patients with impaired neutrophil phagocytosis

BACKGROUND: Critically ill patients with impaired neutrophil phagocytosis have significantly increased risk of nosocomial infection. Granulocyte-macrophage colony-stimulating factor (GM-CSF) improves phagocytosis by neutrophils ex vivo. This study tested the hypothesis that GM-CSF improves neutrophi...

Descripción completa

Detalles Bibliográficos
Autores principales: Pinder, Emma M, Rostron, Anthony J, Hellyer, Thomas P, Ruchaud-Sparagano, Marie-Helene, Scott, Jonathan, Macfarlane, James G, Wiscombe, Sarah, Widdrington, John D, Roy, Alistair I, Linnett, Vanessa C, Baudouin, Simon V, Wright, Stephen E, Chadwick, Thomas, Fouweather, Tony, Juss, Jatinder K, Chilvers, Edwin R, Bowett, Susan A, Parker, Jennie, McAuley, Daniel F, Conway Morris, Andrew, Simpson, A John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Critical Care
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6166597/
https://www.ncbi.nlm.nih.gov/pubmed/30064991
http://dx.doi.org/10.1136/thoraxjnl-2017-211323

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6166597/
https://www.ncbi.nlm.nih.gov/pubmed/30064991
http://dx.doi.org/10.1136/thoraxjnl-2017-211323

Ejemplares similares